Planned milestones

•    Completion of the serial production development of the P.L.E.A.S.E.^® devices
•    Completion of the infertility patch projects for triptoreline and FSH
•    Clinical pharmacodynamic studies for triptoreline and FSH to be finalized
•    Clinical pivotal studies for triptoreline and FSH
•    Regulatory approval for P.L.E.A.S.E. - IVF in Europe
•    Licensing of P.L.E.A.S.E. – IVF in other regions such as US and Japan
•    Preclinical development of other therapy areas with the goal to license